Please login to the form below

Not currently logged in


This page shows the latest influenza news and features for those working in and with pharma, biotech and healthcare.

Roche’s flu pill Xofluza gains EU approval

Roche’s flu pill Xofluza gains EU approval

Xofluza offers patients the first novel mechanism of action for treating influenza approved in Europe in almost 20 years. ... found that the drug had a statistically significant prophylactic effect on influenza occurrences.

Latest news

More from news
Approximately 19 fully matching, plus 205 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Case study

    influenza vaccine.

  • Fake News is Bad for your Health

    Epidemics of measles are occurring across Europe. Rates of vaccination for influenza, HPV, tetanus and polio have also declined.

  • To track disease, follow the money

    The way that influenza spreads can be tracked by tools such as Flusurvey,(1)  which produces rapidly-updated heatmaps of illness across the country.

  • Influenza

    Agency: BASTARD. LONDON. Product: Self Promotion. Client: Self Promotion. Therapy area: Self Promotion. View the PMHub profile for: BASTARD. LONDON.

More from PMHub
Approximately 2 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...